Anabion Pharmaceutical Industries
About Us
Anabion Pharmaceutical Industries is a biotech company which rapidly develops its R&D infrastructure and commercial-scale manufacturing.
Our new manufacturing facility is built to produce pharmaceutical products for human use based on monoclonal antibodies for the treatment of cancers, autoimmune and orphan disorders.
Our portfolio includes therapeutic monoclonal antibodies and small molecules, proven to be most effective drugs in clinical use over the years.
- PD-1/PDL-1 inhibitors,
- IL-17 inhibitor,
- IL-6R inhibitor,
- rituximab biosimilar
- bevacizumab biosimilar
- trastuzumab biosimilar
- eculizumab biosimilar
Partnering
Our goal is to make the treatment more affordable to the patients and to be flexible accommodating the business needs of the partners. We therefore offer different ways to cooperate.
1
Distribution
We’re looking for the partners with experience in oncology, dermatology and rheumatology to market and to distribute our products.
2
Licensing
We offer attractive opportunities for those partners whose goal is to quickly expand their portfolio, and to generate new revenue streams.
3
Technology Transfer
We are ready to share our expertise, as well as the technological solutions to increase the competitiveness of the partners in their target markets.
Anabion Pharmaceutical Industries
Contacts
Anabion Pharmaceutical Industries, Ltd.
Address: Unit KLP FZ No. 11 Taweelah, Abu Dhabi, United Arab Emirates
Email: info@anabion.ae